These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 4287511)

  • 21. Renal failure in advanced liver disease.
    Baldus WP
    Prog Liver Dis; 1972; 4():251-67. PubMed ID: 4347066
    [No Abstract]   [Full Text] [Related]  

  • 22. Renal concentrating ability in cirrhosis. I. Changes associated with the clinical status and course of the disease.
    Vaamonde CA; Vaamonde LS; Morosi HJ; Klingler EL; Papper S
    J Lab Clin Med; 1967 Aug; 70(2):179-94. PubMed ID: 6029052
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effect differences between angiotensin II and noradrenalin in reference to diuresis, sodium and potassium excretion in healthy persons and patients with kidney diseases].
    Pogglitsch H; Giessauf W; Stöckl G; Feldner H; Kratochvil K
    Wien Z Inn Med; 1970; 51(7):324-9. PubMed ID: 4331448
    [No Abstract]   [Full Text] [Related]  

  • 24. Participation of renal prostaglandins in the nephrotic syndrome.
    Ruilope L; Millet VG; Alcazar JM; Prieto C; Tresguerres JA; Garcia-Robles R; Sancho J; Rodicio JL
    Proc Eur Dial Transplant Assoc; 1983; 19():738-43. PubMed ID: 6576332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatic hemodynamics and the renin-angiotensin-aldosterone system in cirrhosis.
    Bosch J; Arroyo V; Betriu A; Mas A; Carrilho F; Rivera F; Navarro-Lopez F; Rodes J
    Gastroenterology; 1980 Jan; 78(1):92-9. PubMed ID: 7350041
    [No Abstract]   [Full Text] [Related]  

  • 26. Refractory ascites in cirrhosis: roles of volume expansion and plasma atrial natriuretic factor level elevation.
    Wong F; Tobe S; Legault L; Logan AG; Skorecki K; Blendis LM
    Hepatology; 1993 Sep; 18(3):519-28. PubMed ID: 8395457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of dipyridamole on kidney function in cirrhosis.
    Llach J; Ginès P; Arroyo V; Salmerón JM; Ginès A; Jiménez W; Gaya J; Rivera F; Rodés J
    Hepatology; 1993 Jan; 17(1):59-64. PubMed ID: 8423042
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of aldosterone and salt intake on renal and pressor actions of angiotensin.
    Healy JK; Suszkiw JB; Dennis VW; Schreiner GE
    Nephron; 1966; 3(6):329-43. PubMed ID: 4289495
    [No Abstract]   [Full Text] [Related]  

  • 29. [Angiotensin intradermoreaction in patients with liver cirrhosis in the ascitic phase. Results and interpretation in relation to the pathogenesis of the altered hydrosaline metabolism in cirrhogenic liver diseases].
    Santambrogio S; Natangelo R; Lucchelli PD
    Minerva Med; 1966 Dec; 57(101):4366-71. PubMed ID: 4289384
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of furosemide uring antidiuresis and antinatriuresis induced by angiotensin.
    Radó JP; Borbély L; Takó J; Bános C
    Med Pharmacol Exp Int J Exp Med; 1967; 17(4):373-7. PubMed ID: 4296659
    [No Abstract]   [Full Text] [Related]  

  • 31. Aldosterone in clinical medicine.
    Wolff HP
    Acta Endocrinol (Copenh); 1968; ():Suppl 124:65+. PubMed ID: 4295469
    [No Abstract]   [Full Text] [Related]  

  • 32. [On the direct and indirect renal effects of angiotensin II in humans].
    Agnoli GC; Cariani A; Farné F; Gritti FM; Suriani L
    Boll Soc Ital Biol Sper; 1968 Dec; 44(24):2189-93. PubMed ID: 4311275
    [No Abstract]   [Full Text] [Related]  

  • 33. Inappropriately low angiotensin II generation: a factor determining reduced kidney function and survival in patients with decompensated cirrhosis.
    Sansoé G; Silvano S; Mengozzi G; Todros L; Smedile A; Touscoz G; Rosina F; Rizzetto M
    J Hepatol; 2004 Mar; 40(3):417-23. PubMed ID: 15123355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renin, angiotensin, aldosterone and hormonal regulation of arterial pressure and salt balance. Introductory remarks.
    Laragh JH
    Fed Proc; 1967; 26(1):39-41. PubMed ID: 4289566
    [No Abstract]   [Full Text] [Related]  

  • 35. Renal function, sodium excretion and the renin-angiotensin-aldosterone system in relation to blood pressure. An epidemiological and physiological study.
    Ljungman S
    Acta Med Scand Suppl; 1982; 663():108. PubMed ID: 6983814
    [No Abstract]   [Full Text] [Related]  

  • 36. Renal function in the iso- lated perfused kidney.
    Berkowitz HD; Miller LD; Itskovitz HD; Bovée KC
    Surg Gynecol Obstet; 1968 Dec; 127(6):1257-66. PubMed ID: 4302514
    [No Abstract]   [Full Text] [Related]  

  • 37. Role of aldosterone in edema formation.
    Wolff HP; Blaise BH; Düsterdieck G; Jahnecke J; Kobayashi T; Krück F; Lommer D; Schieffer H
    Ann N Y Acad Sci; 1966 Nov; 139(2):285-94. PubMed ID: 4291331
    [No Abstract]   [Full Text] [Related]  

  • 38. [Changes in kidney function values under angiotensin effect in various kidney diseases].
    Pogglitsch H; Giessauf W; Feldner H; Stöckl G; Oser W
    Wien Klin Wochenschr; 1969 Mar; 81(10):170-5. PubMed ID: 4332262
    [No Abstract]   [Full Text] [Related]  

  • 39. Release of renin by human kidney slices, in vitro effect of angiotensin II, norepinephrine and aldosterone.
    Rosset E; Veyrat R
    Rev Eur Etud Clin Biol; 1971 Oct; 16(8):792-4. PubMed ID: 4331508
    [No Abstract]   [Full Text] [Related]  

  • 40. The effects of aldosterone, angiotensin and electrolytes on kidney glucose-6-phosphate dehydrogenase.
    Caravaca J; Fukuda I; Reeves G; Baronofsky I; Dimond EG
    Bull Osaka Med Sch; 1970 Apr; 16(1):43-9. PubMed ID: 4394078
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.